Farallon Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $46.1M | Buy |
|
|||||
|
2023
Q1 | $29.5M | Sell |
|
|||||
|
2022
Q4 | $12.6M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $15.3M | Sell |
|
|||||
|
2019
Q3 | $14.6M | Sell |
|
|||||
|
2019
Q2 | $75.5M | Buy |
|
|||||
|
2019
Q1 | $64.1M | Buy |
|
|||||
|
2018
Q4 | $39.3M | Buy |
|
|||||
|
2018
Q3 | $55.1M | Buy |
|